Chronic GCPII (glutamate-carboxypeptidase-II) inhibition reduces pT217Tau levels in the entorhinal and dorsolateral prefrontal cortices of aged macaques

Authors

Shveta Bathla, Yale University
Nicolas Barthelemy, Washington University School of Medicine in St. Louis
et al.

Journal

Alzheimer's & Dementia: Translational Research & Clinical Interventions

Publication Date

1-1-2023

Volume

9

Issue

4

First Page

e12431

Document Type

Open Access Publication

DOI

10.1002/trc2.12431

Rights and Permissions

Bathla S, Datta D, Liang F, et al. Chronic GCPII (glutamate-carboxypeptidase-II) inhibition reduces pT217Tau levels in the entorhinal and dorsolateral prefrontal cortices of aged macaques. Alzheimer's Dement. 2023; 9:e12431. https://doi.org/10.1002/trc2.12431 © 2023 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals LLC on behalf of Alzheimer's Association. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Recommended Citation

Bathla, Shveta; Barthelemy, Nicolas; and et al., "Chronic GCPII (glutamate-carboxypeptidase-II) inhibition reduces pT217Tau levels in the entorhinal and dorsolateral prefrontal cortices of aged macaques." Alzheimer's & Dementia: Translational Research & Clinical Interventions. 9, 4. e12431 (2023).
https://digitalcommons.wustl.edu/oa_4/3493

Additional Links

Supplemental material is available for this article at publisher site.